#coinfection

A long-term study also found that superinfection—acquiring a second strain of HIV—was not a risk for the transplantees.

The opioid epidemic is principally responsible for a recent increase in infective endocarditis in the United States.

The indication for AbbVie’s regimen includes those with compensated cirrhosis.

Pharmacist-driven hep C treatment sees good cure rates

However, the presence of such persistent virus has not been found to be associated with liver damage.

Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.

Researchers analyzed autopsies among people with HIV who died in New York City since 1984.

Researchers analyzed the association between heavy drinking and immune function in those with untreated HIV.

Study finds the two types of stroke, ischemic and hemorrhagic, have different risk factors.

Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

Researchers compared health outcomes among people with HIV, including those with and without hepatitis C.

Large European study finds that more than 1 in 10 people with HIV acquire HCV again.

Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.

An NIH-sponsored peer-recruitment study is part of a larger push to figure out how to drive up the viral suppression rate in the U.S.

Pharmacists oversaw the delivery of hepatitis C treatment in a recent study.